Alkaloid Content, Antioxidant and Cytotoxic Activities of Various Parts of Papaver somniferum


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Poppy (Papaver somniferum) is a traditional source of isoquinoline alkaloids, especially morphine, codeine and papaverine that exhibit a wide spectrum of therapeutic effects. Due to beneficial properties, poppy has been used by humankind for several thousand years and is still being used around the world. The present study was aimed to investigate alkaloid composition and biological activity of various parts of the plant (leaves, stems, roots, capsules, flowers, seeds) in an ornamental variety of P. somniferum. The alkaloid content rangedwithin 0.16 – 6.5 mg/g fresh weight of raw plant material. The major components of the alkaloid fraction were papaverine (37.7 – 2062.9 μg/g), codeine (7.4 – 1280.5 μg/g) and morphine (3.25 – 929.3 μg/g). The P. somniferum alkaloid extract produced a strong antioxidant effect, which was evaluated using the radical-scavenging DPPH, ABTS and FRAP assays. The antioxidant properties were characterized by IC50 values ranging within 35.1 – 157.6 μg/mL for DPPH radical and 138.5 – 306.3 μg/mL for ABTS∙•+ radical scavenging. The ferric reducing antioxidant power (FRAP) values varied from 59.75 to 1348.71 mM FeSO4/g extract. The alkaloid extract was active against all human tumor cell lines studied (HeLa, Caco-2, MCF-7, CCRF-CEM and CEM/ADR 5000). The methanol extract exhibited a pronounced cytotoxicity against most of cancer cell lines studied, especially those with a low expression of ABC transporters.

About the authors

Farukh Sharopov

Department of Pharmaceutical Technology, Avicenna Tajik State Medical University; Institute of Pharmacy and Molecular Biotechnology, Heidelberg University

Author for correspondence.
Email: sharopov@uni-heidelberg.de
Tajikistan, Rudaki 139, Dushanbe, 734003; Im Neuenheimer Feld 364, Heidelberg, D-69120

Abdujabbor Valiev

Department of Pharmaceutical Technology, Avicenna Tajik State Medical University

Email: sharopov@uni-heidelberg.de
Tajikistan, Rudaki 139, Dushanbe, 734003

Isomiddin Gulmurodov

Department of Pharmaceutical Technology, Avicenna Tajik State Medical University

Email: sharopov@uni-heidelberg.de
Tajikistan, Rudaki 139, Dushanbe, 734003

Mansour Sobeh

Institute of Pharmacy and Molecular Biotechnology, Heidelberg University

Email: sharopov@uni-heidelberg.de
Germany, Im Neuenheimer Feld 364, Heidelberg, D-69120

Prabodh Satyal

Department of Chemistry, University of Alabama in Huntsville

Email: sharopov@uni-heidelberg.de
United States, Huntsville, AL, 35899

Michael Wink

Institute of Pharmacy and Molecular Biotechnology, Heidelberg University

Email: sharopov@uni-heidelberg.de
Germany, Im Neuenheimer Feld 364, Heidelberg, D-69120


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies